[对血友病的基因疗法]
1Department of Hematology, Saitama Medical University.
概括
血友病A和B的基因疗法提供了一个新的治疗选择. 在2022年获得批准,单次输液可显著减少大多数患者需要凝血因子注射和出血事件的需要.
科学领域:
- * 血液学和基因治疗
- * 分子和细胞生物学
背景情况:
- *血友病A和B是遗传性出血障碍,需要终身的凝血因子替代.
- *以前的治疗涉及频繁的静脉注射,影响患者的生活质量.
- *基因疗法成为解决缺陷根源的有希望的替代方案.
研究的目的:
- * 审查血友病A和B的基因疗法的最新进展.
- *讨论临床试验数据和已批准的基因疗法的结果.
- * 确定该领域剩余的挑战和未满足的需求.
主要方法:
- *对血友病基因疗法的关键第三期临床试验的审查.
- *对治疗结果的有效性,安全性和持久性数据的分析.
- * 讨论载体学,包括腺相关病毒 (AAV) 载体和肝脏特异性促进体.
主要成果:
- * 血友病A和B的基因疗法将于2022年在美国和欧盟获得批准.
- * 一次腺相关病毒载体输注可以在几周内增加凝血因子水平 (FVIII/FIX).
- * 大约90%的治疗患者不再需要因子替代,每年出血率显著降低.
结论:
- *基因疗法代表了对血友病A和B的转变性治疗,提供长期纠正.
- *当前疗法的成功凸显了基于AAV的基因转移对遗传疾病的潜力.
- *需要进一步的研究来解决长期的安全性,可访问性和更广泛应用的潜力.
相关概念视频
Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
What is Genetic Engineering?
75.6K
Overview
75.6K
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Microorganisms in Medicine and Therapeutics
349
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
349


